1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,444 | 0,487 | 25.10. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | LIFECARE ASA: Extraordinary General Meeting | 1 | Oslo Børs | ||
| Mi | Lifecare ASA: Proposed partially underwritten rights issue | 2 | Oslo Børs | ||
| Mi | Lifecare ASA: Key information relating to the proposed partially underwritten rights issue | 4 | Oslo Børs | ||
| 26.09. | Lifecare ASA: Mandatory notification of trade | - | Oslo Børs | ||
| 24.09. | Lifecare ASA: Lifecare strengthens miniaturisation roadmap with new patent applications | 1 | Oslo Børs | ||
| LIFECARE ASA Aktie jetzt für 0€ handeln | |||||
| 15.09. | Lifecare ASA: LIFECARE RESUBMITS APPLICATION FOR FIRST-IN-HUMAN CLINICAL STUDY | 1 | Oslo Børs | ||
| 27.08. | Lifecare ASA: Reconfirmed positive results in veterinary study support path toward market entry | 3 | Oslo Børs | ||
| 20.08. | LIFE: Lifecare ASA Q2 2025 results | 4 | Oslo Børs | ||
| 13.08. | Lifecare ASA: Lifecare advances CE mark preparation for its groundbreaking medical device | 4 | Oslo Børs | ||
| 12.08. | Lifecare ASA: Invitation to presentation of Q2 2025 results 20 August at 10.45 CEST | 3 | Oslo Børs | ||
| 05.08. | Lifecare ASA Secures REK Ethics Approval For First-In-Human CGM Trial | 2 | RTTNews | ||
| 05.08. | Lifecare ASA: Lifecare receives ethics approval to initiate first-in-human trial in Norway | 3 | Oslo Børs | ||
| 08.07. | Lifecare ASA: Lifecare achieves full radio frequency compliance for CGM implant clearing the way for CE mark of electronics | 2 | Oslo Børs | ||
| 01.07. | Lifecare ASA: Lifecare advances electromagnetic compatibility compliance testing for CGM implant | 1 | Oslo Børs | ||
| 25.06. | Lifecare ASA: Share capital increase registered | 2 | Oslo Børs | ||
| 13.06. | Lifecare ASA: Final results following expiry of the exercise period for the Warrants issued in connection with the Rights Issue | 2 | Oslo Børs | ||
| 13.06. | Lifecare ASA: Notification of trade - exercise of warrants | - | Oslo Børs | ||
| 13.06. | Lifecare ASA: Last day of the Exercise Period for the Warrants issued in connection with the Rights Issue | 1 | Oslo Børs | ||
| 06.06. | Lifecare ASA: Notification of trade - exercise of warrants | 1 | Oslo Børs | ||
| 06.06. | Lifecare ASA: Last day of trading in the Warrants issued in connection with the Rights Issue | 1 | Oslo Børs |
1 2 Weiter >>
27 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ROKU | 83,37 | +0,69 % | Roku may have finally fixed the biggest headache in TV streaming - here's how | ||
| SERNOVA BIOTHERAPEUTICS | 0,097 | -2,51 % | Sernova Biotherapeutics Announces $13 Million Debt-to-Equity Conversion Eliminating Significant Financing Overhang | Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - October 1, 2025) - Sernova Biotherapeutics (TSX: SVA) (OTCQB: SEOVF) (FSE: PSH0) ("Sernova") a leading regenerative medicine company focused... ► Artikel lesen | |
| BOSTON SCIENTIFIC | 87,20 | +0,23 % | Boston Scientific Corp Q3 Profit Increases, Beats Estimates | WASHINGTON (dpa-AFX) - Boston Scientific Corp (BSX) released a profit for its third quarter that Increased from last year and beat the Street estimates.The company's bottom line totaled $755... ► Artikel lesen | |
| PAUL HARTMANN | 230,00 | -0,86 % | Januar bis Juni 2025: PAUL HARTMANN behauptet sich in herausforderndem Marktumfeld | Heidenheim (ots) - - Umsatzerlöse steigen auf 1.214,0 Mio. EUR, organisches Umsatzwachstum von 1,6 % - Bereinigtes EBITDA liegt bei 125,8 Mio. EUR, bereinigte EBITDA-Rendite bei 10,4 % - Transformationsprogramm... ► Artikel lesen | |
| SYSMEX | 10,400 | 0,00 % | Sysmex, QIAGEN Announce Exclusive Distribution Partnership For Diagnostic Products In Japan | TOKYO (dpa-AFX) - Sysmex Corporation (SSMXY.PK) and QIAGEN K.K., the Japanese subsidiary of QIAGEN N.V., announced on Wednesday that they have entered into a partnership for clinical diagnostic... ► Artikel lesen | |
| ADDLIFE | 18,560 | -0,96 % | AddLife AB: Interim Report January 1 - September 30, 2025 | Good organic growth and strong earnings development"AddLife's companies performed strongly during the quarter. Organic growth was solid, margin improvement continued, earnings increased significantly... ► Artikel lesen | |
| EMBECTA | 12,200 | -1,61 % | Dividendenbekanntmachungen (29.08.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACNB CORPORATION US0008681092 0,34 USD 0,2911 EUR ADVANCED DRAINAGE SYSTEMS INC US00790R1041 0,18 USD 0,1541 EUR AEBI SCHMIDT HOLDING... ► Artikel lesen | |
| ENOVIS | 28,200 | -0,70 % | Enovis Corporation: Enovis completes sale of its Dr. Comfort Footcare Solutions business for proceeds of up to $60 million | Wilmington, DE, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Enovis Corporation ("Enovis" or "the Company") (NYSE: ENOV), an innovation-driven medical technology growth company, today announced the sale of its... ► Artikel lesen | |
| KANGJI MEDICAL | 0,955 | 0,00 % | KANGJI MEDICAL (09997): DISCLOSURE OF DEALINGS UNDER RULE 22 OF THE TAKEOVERS CODE | ||
| PULMONX | 1,340 | 0,00 % | Pulmonx Corporation: Pulmonx to Report Third Quarter 2025 Financial Results on October 29, 2025 | ||
| KOOTH | 1,500 | +3,45 % | Kooth inks contract with New Jersey for further year under same terms | ||
| PEIJIA MEDICAL | 0,645 | -1,53 % | Peijia Medical Announces 2025 Interim Results | HONG KONG, Aug. 25, 2025 /PRNewswire/ -- Peijia Medical (9996.HK), a leading Chinese domestic player in the high-growth transcatheter valve therapeutics and neurovascular interventions markets... ► Artikel lesen | |
| SI-BONE | 13,000 | +0,78 % | SI-BONE, Inc.: SI-BONE To Report Third Quarter 2025 Financial Results on November 10, 2025 | ||
| BACTIGUARD | 1,255 | -5,99 % | Bactiguard Holding AB: Bactiguard Holding AB's interim report third quarter 2025 | Continued profitability and clinical evidence supporting future growth
Third quarter 2025 (July - September)
Total revenue amounted to SEK 48.4 (73.9) million, a decrease of SEK 25.5 million corresponding... ► Artikel lesen | |
| SCIBASE | 0,004 | -36,67 % | Nomination Committee appointed for SciBase Holding's Annual General Meeting in 2026 | STOCKHOLM, Oct. 22, 2025 /PRNewswire/ -- The following people have been appointed as members of SciBase Holding's nominating committee for the Annual General Meeting in 2026:
Anders... ► Artikel lesen |
LIFECARE ASA gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell -7,17 % bei einem Aktienkurs von 0,427 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu LIFECARE ASA finden Sie auf Wallstreet Online.